(Q45963893)

18 December 2017

title

Improved freedom from PSA failure with whole pelvic irradiation for high-risk prostate cancer. (English)

1 reference

18 December 2017

author name string

Seaward SA

1

1 reference

18 December 2017

Weinberg V

2

1 reference

18 December 2017

Lewis P

3

1 reference

18 December 2017

Leigh B

4

1 reference

18 December 2017

Phillips TL

5

1 reference

18 December 2017

Roach M 3rd

6

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 December 1998

1 reference

18 December 2017

International Journal of Radiation Oncology Biology Physics

published in

1 reference

18 December 2017

volume

42

1 reference

18 December 2017

issue

5

1 reference

18 December 2017

page(s)

1055-1062

1 reference

18 December 2017

The value of extended field radiation therapy in carcinoma of the prostate

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900282-X

7 January 2021

Nonrandomized evaluation of pelvic lymph node irradiation in localized carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900282-X

7 January 2021

Comparison of whole pelvis versus small-field radiation therapy for carcinoma of prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900282-X

7 January 2021

Local control and survival after external irradiation for adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900282-X

7 January 2021

External beam radiotherapy in cancer of the prostate. The University of Arizona experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900282-X

7 January 2021

Elective pelvic irradiation in stage A2, B carcinoma of the prostate: analysis of RTOG 77-06

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900282-X

7 January 2021

Carcinoma of the prostate: treatment with external radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900282-X

7 January 2021

Prostate carcinoma: radiation treatment of the primary and regional lymphatics

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900282-X

7 January 2021

Megavoltage radiation therapy for carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900282-X

7 January 2021

Tumor control in definitive irradiation of localized carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900282-X

7 January 2021

Prostatic carcinoma: limited field irradiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900282-X

7 January 2021

The role of radiation therapy in stages A2 and B adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900282-X

7 January 2021

Stage C adenocarcinoma of the prostate. An analysis of 551 patients treated with external beam radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900282-X

7 January 2021

Technical factors affecting morbidity in definitive irradiation for localized carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900282-X

7 January 2021

Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900282-X

7 January 2021

You say either, I say either, but let's not call the whole thing off: models for predicting the risk of lymph node involvement in patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900282-X

7 January 2021

Defining treatment margins for six field conformal irradiation of localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900282-X

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900282-X

7 January 2021

Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: Implications for patient selection in the radiotherapeutic management of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900282-X

7 January 2021

Indications for Seminal Vesicle Biopsy and Laparoscopic Pelvic Lymph Node Dissection in Men With Localized Carcinoma of Prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900282-X

7 January 2021

Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900282-X

7 January 2021

Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900282-X

7 January 2021

Prostate carcinoma patients upstaged by imaging and treated with irradiation. An outcome-based analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900282-X

7 January 2021

Correlation of pretherapy prostate cancer characteristics with histologic findings from pelvic lymphadenectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900282-X

7 January 2021

A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900282-X

7 January 2021

10.1016/S0360-3016(98)00282-X

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017